An ion pairing approach to increase the loading of hydrophilic and lipophilic drugs into PEGylated PLGA nanoparticles

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 71, Issue 2, 2009, Pages 231-242

  Dalwadi, Gautam ^a   Sunderland, Bruce ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

Ion pairing; Microencapsulation; Nanoparticles; PEGylation; s o w

Indexed keywords

DEXTRAN SULFATE; LEUCINE ENKEPHALIN[2 DEXTRO ALANINE 6 ARGININE]; LOPERAMIDE; MACROGOL; NANOPARTICLE; POLYGLACTIN;

ARTICLE; DENSITY; DIFFUSION; DRUG FORMULATION; DRUG RELEASE; EMULSION; HYDROPHILICITY; LIPOPHILICITY; NANOENCAPSULATION; PARTICLE SIZE; ZETA POTENTIAL;

ANALGESICS; ANTIDIARRHEALS; CHEMISTRY, PHARMACEUTICAL; DEXTRAN SULFATE; DRUG CARRIERS; ENKEPHALIN, LEUCINE-2-ALANINE; HYDROPHOBICITY; LACTIC ACID; LOPERAMIDE; MOLECULAR WEIGHT; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; SOLVENTS;

EID: 59749095868     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.08.004     Document Type: Article

References (41)

1. Beletsi A., Panagi Z., and Avgoustakis K. Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers. Int. J. Pharm. 298 (2005) 233-241
2. Xuedong Y., Scherphof G.L., and Kamps J.A.A.M. Liposome opsonization. J. Liposome Res. V15 (2005) 109-139
3. Barenholz Y. Liposome application: problem and prospectus. Curr. Opin. Coll. Interf. Sci. 6 (2001) 66-77
4. Gref R., Minamitake Y., Peracchia M.T., Turbetskoy V., Trochillin V., and langer R. Biodegrdable long circulating polymeric nanosphere. Science 263 (1995) 1600-1603
5. Gref R., Luck M., Quellec P., Marchand M., Dellacherie E., Harnisch S., Blunk T., and Muller R.H. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Coll. Surf. B Biointerf. 18 (2000) 301-313
6. Ichiro Y., and (D P.o.n.a.c.p. l-lactic acid) microspheres formed by oil in water solvent evaporation. J. Pharm. Sci. 81 (1992) 899-903
7. Niwa T., Takeuchi H., Hino T., Kunou N., and Kawashima Y. In vitro drug release behaviour of d,l-lactide/glycolide copolymer (PLGA) nanophere with nafarelin acetate by a novel spontaneous emulsification solvent diffusion method. J. Pharm. Sci. 83 (1994) 727-732
8. 2-swollen polymer microparticles. J. Supercriti. Fluids 41 (2007) 293-298
9. Powers M.E., Matsuura J., Brassell J., Manning M.C., and Shefter E. Enhanced solubility of proteins and peptides in nonpolar solvents through hydrophobic ion pairing. Biopolymers 33 (1993) 927-932
10. Wencho B., Jiaxiang Z., Jiufu L., and Denxi W. PLGA microsphere with high drug loading and high encapsulation efficiency prepared by a novel solvent evaporation technique. J. Microencap. 23 (2006) 471-479
11. Yamaguchi Y., Takenaga M., Kitagawa A., Ogawa Y., Mizushima Y., and Igarashi R. Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives. J. Control. Release 81 (2002) 235-249
12. Takenaga M., Yamaguchi Y., Kitagawa A., Ogawa Y., Mizushima Y., and Igarashi R. A novel sustained-release formulation of insulin with dramatic reduction in initial rapid release. J. Control. Release 79 (2002) 81-91
13. Ralf L., Alexandra A., Bernhard T., Felix G., and Olaf Z. Poster Abstracts. J. Liposome Res. V13 (2003) 51-95
14. Morita T., Sakamura Y., Horikiri Y., Suzuki T., and Yoshino H. Protein encapsulation into biodegradable microspheres by a novel S/O/W emulsion method using poly(ethylene glycol) as a protein micronization adjuvant. J. Control. Release 69 (2000) 435-444
15. Giagnoni G., Casiraghi L., Senini D., Revel M., Parolaro M., and Sala E. Loperamide: evidence of interaction with u and b opioid receptors. Life Sci. 33 (1983) 315-318
16. TM (RMP-7). Brain Res. 801 (1998) 259-266
17. Alyautdin R.N., Petrov V.E., Langer K., Berthold A., Kharkevich D.A., and Kreuter J. Delivery of loperamide across the blood brain barrier with polysorbate 80 coated polybutylcyanoacrylate nanoparticles. Pharm. Res. 14 (1997) 325-328
18. Beletsi A., Leontiadis L., Klepetsanis P., Ithakissios D.S., and Avgoustakis K. Effect of preparative variables on the properties of poly(dl-lactide-co-glycolide)-methoxypoly(ethyleneglycol) copolymers related to their application in controlled drug delivery. Int. J. Pharm. 182 (1999) 187-197
19. Gilding D.K., and Reed A.M. Biodegradable polymers for use in surgery - polyglycolic/poly(actic acid) homo- and copolymers: 1. Polymer 20 (1979) 1459-1464
20. Dalwadi G., and Sunderland V.B. Purification of pegylated nanoparticles using tangential flow filtration (TFF). Drug Dev. Ind. Pharm. 33 (2007) 1030
21. Dalwadi G., and Sunderland V.B. Comparison and validation of drug loading parameters of PEGylated nanoparticles purified by a diafiltration centrifugal device (DCD) and tangetial flow filtration (TFF). Drug Dev. Ind. Pharm. 29 (2008) 1-12
22. Du Y.J., Lemstra P.J., Nijenhuis A.J., Aert H.A.M., and Bastiaansen C. ABA type copolymer of lactide poly(ethylene glycol). Kinet. Mech. Model studies Macromol. 28 (1995) 2124-2132
23. Hagan S.A., Coombes A.G.A., Garnett M.C., Dunn S.E., Davies M.C., Illum L., Davis S.S., Harding S.E., Purkiss S., and Gellert P.R. Polylactide-poly(ethylene glycol) copolymers as drug delivery systems. 1. Characterization of water dispersible Micelle-forming systems. Langmuir 12 (1996) 2153-2161
24. Niwa T., Takeuchi H., Hino T., Nohara M., and Kawashima Y. Biodegradable submicron carriers for peptide drugs: preparation of d,l-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate by a novel emulsion-phase separation method in an oil system. Int. J. Pharm. 121 (1995) 45-54
25. Niwa T., Takeuchi H., Hino T., Kunou N., and Kawashima Y. Preparations of biodegradable nanospheres of water-soluble insoluble drugs with - lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method and the drug release behavior. J. Control. Release 25 (1993) 89-98
26. Budhian A., Siegel S.J., and Winey K.I. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. Int. J. Pharm. 336 (2007) 367-375
27. Riley T., Stolnik S., Heald C.R., Xiong C.D., Garnett M.C., Illum L., Davis S.S., Purkiss S.C., Barlow R.J., and Gellert P.R. Physicochemical evaluation of nanoparticles assembled from poly(lactic acid)-Poly(ethylene glycol) (PLA-PEG) block copolymers as drug delivery vehicles. Langmuir 17 (2001) 3168-3174
28. Mittal G., Sahana D.K., Bhardwaj V., and Ravi Kumar M.N.V. Estradiol loaded PLGA nanoparticles for oral administration: Effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J. Control. Release 119 (2007) 77-85
29. Dalwadi G., Benson H.A., and Chen Y. Comparison of diafiltration and tangential flow filtration for purification of nanoparticle suspensions. Pharm. Res. 22 (2005) 2152-2162
30. Quellec P., Gref R., Perrin L., Dellacherie E., Sommer F., Verbavatz J.M., and Alonso M.J. Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization. J. Biomed. Mater. Res. 42 (1998) 45-54
31. Quellec P., Gref R., Dellacherie E., Sommer F., Tran M.D., and Alonso M.J. Protein encapsulation within poly(ethylene glycol)-coated nanospheres. II. Controlled release properties. J. Biomed. Mater. Res. 47 (1999) 388-395
32. Carstens M.G., De Jong P.H.J.L.F., Van Nostrum C.F., Kemmink J., Verrijk R., De Leede L.G.J., Crommelin D.J.A., and Hennink W.E. The effect of core composition in biodegradable oligomeric micelles as taxane formulations. Eur. J. Pharm. Biopharm. 68 (2008) 596-606
33. Spalla O. Nanoparticle interactions with polymers and polyelectrolytes. Curr. Opin. Coll. Interf. Sci. 7 (2002) 179-185
34. Peracchia M.T., Gref R., Minamitake Y., Domb A., Lotan N., and Langer R. PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: investigation of their drug encapsulation and release characteristics. J. Control. Release 46 (1997) 223-231
35. Cheng J., Teply B.A., Sherifi I., Sung J., Luther G., Gu F.X., Levy N.E., Radovic M.A.F., Langer R., and Farokhzad O.C. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 28 (2007) 869-876
36. Usui F., Maeda K., Kusai A., Nishimura K., and Yamamoto K. Inhibitory effect of water soluble polymers on precipitation of RS-8359. Int. J. Pharm. 154 (1997) 59-66
37. Raghvan S.L., Trividic A., Davis A.F., and Hadgraft J. Crystallisation of hydrocortisone acetate: influence of polymers. Int. J. Pharm. 212 (2001) 213-221
38. Loftsson T., Fridriskdottir H., and Gudmundsdottir T.K. The effect of water soluble polymers on aqueous solubility of drugs. Int. J. Pharm. 127 (1996) 293-296
39. Yu-Hsing T., Allen L.V., and Da-Peng W. Stability of loperamide hydrochloride in aqueous solutions as determined by high performance liquid chromatography. Int. J. Pharm. 51 (1989) 157-160
40. Patel, Nano and micropatriculate formulation of loperamide HCl M. Pharm thesis. School of Pharmacy, Curtin University of Technology Perth, Western Australia, 2007.
41. Kawashima Y., Yamamoto H., Takeuchi H., Hino T., and Niwa T. Properties of a peptide containing dl-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods. Eur. J. Pharm. Biopharm. 45 (1998) 41-48